Abstract
Dermatofibrosarcoma protuberans (DFSP) is a locally aggressive cutaneous tumor that usually does not metastasize. Clinically, it may present as a reddish macule to protuberant nodule affecting the trunk and proximal extremities of young and middle-aged adults. Histologically, it is characterized by a monomorphous storiform proliferation of spindle cells, involving the dermis and hypodermis, with a honeycomb pattern of infiltration of the subcutaneous fat. In case of difficulty in diagnosis, immunohistochemical markers (especially CD34) are highly sensitive for DFSP. It is important to remember that the rarity of DFSP, its resemblance to hypertrophied scars and keloids, and its appearance at trauma sites sometimes make the diagnosis of DFSP difficult and delayed.
In the literature, DSFP was not described in a child until 1957. Here we report an instance of DFSP at an unusual site in a 9-year-old child, which was the location of a previous central venous line insertion in the left supraclavicular area. A complete excision of the tumor with a wide surgical margin of 3cm of visibly uninvolved tissue was performed, followed by a deltopectoral flap and skin split graft. Postoperatively, the patient’s general condition was stable and he was discharged after 5 days to be followed up 3 months later in our clinic.
References
Fletcher CD, Evans BJ, MacArtney JC, et al. Dermatofibrosarcoma protuberans: a clinicopathological and immunohistochemical study with a review of the literature. Histopathology. 1985; 9 (9): 921–38
Weiss SW. Histological typing of soft tissue tumours. 2nd ed. WHO international histological classification of tumours. Berlin: Springer, 1994
Koh CK, Ko CB, Bury HP, et al. Dermatofibrosarcoma protuberans. Int J Dermatol. 1995; 34: 256–60
Taylor RW, Helwig EB. Dermatofibrosarcoma protuberans: a study of 115 cases. Cancer. 1962; 15: 717–25
Gloster HM. Dermatofibrosarcoma protuberans. J Am Acad Dermatol. 1996; 36: 355–74
Chaung TY, Su WPD, Muller SA. Incidence of cutaneous T-cell lymphoma and other rare skin cancers in a defined population. J Am Acad Dermatol. 1990; 23: 254–6
Enzinger FM, Weiss SW. Soft tissue tumors. 3rd ed. St Louis (MO): Mosby, 1995: 325–37
Pack GT, Tabah EJ. Dermatofibrosarcoma protuberans: a report of thirty-nine cases. AMA Arch Surg. 1951; 62: 391–411
Hadju SI. Pathology of soft tissue tumors. 1st ed.Philadelphia (PA): Lea & Febiger, 1979: 82
Fletcher CD, Theaker JM, Flanagan A, et al. Pigmented dermatofibrosarcoma protuberans (Bednar tumour): melanocytic colonization or neuroectodermal differentiation? A clinicopathological and immunohistochemical study. Histopathology. 1988; 13: 631–43
Prieto VG, Reed JA, Shea CR. CD34 immunoreactivity distinguishes between scar tissue and residual tumor in re-excisional specimens of dermatofibrosarcoma protuberans. J Cutan Pathol. 1994; 21: 324–9
Mark RJ, Bailet JW, Tran LM, et al. Dermatofibrosarcoma protuberans of the head and neck: a report of 16 cases. Arch Otolaryngol Head Neck Surg. 1993; 119: 891–6
Gutierrez G, Ospina JE, de Baez NE, et al. Dermatofibrosarcoma protuberans. Int J Dermatol. 1984; 23: 396–401
Escalona-Zapata J, Alvarez Fernandez E, Llorca Escuin F. The fibroblastic nature of dermatofibrosarcoma protuberans: a tissue culture and ultrastructural study. Virchows Arch A Pathol Anat Histol. 1981; 391: 165–75
Hashimoto K, Brownstein MH Jakobiec FA. Dermatofibrosarcoma protuberans: a tumor with perineural and endoneural features. Arch Dermatol. 1974; 11: 874–5
Diaz-Cascajo C. Myoid differentiation in dermatofibrosarcoma protuberans and its fibrosarcomatous variant. J Cutan Pathol. 1997; 24: 197–8
Laurier R, Wolff HH, Jones RE. An immunohistochemical study of dermatofibrosarcoma protuberans supports its fibroblastic character and contradicts neuroectodermal or histiocytic components. Am J Dermatopathol. 1990; 12: 25–30
Pedeutour F, Simon MP, Minoletti F. Translocation, t(17;22)(q22;q13), in dermatofibrosarcoma protuberans: a new tumor-associated chromosome rearrangement. Cytogenet Cell Genet. 1996; 72: 171–4
Pedeutour F, Lacour JP, Perrin C. Another case of t(17;22)(q22;q13) in an infantile dermatofibrosarcoma protuberans. Cancer Genet Cytogenet. 1996; 89: 175–6
Craver RD, Correa H, Kao Y, et al. Dermatofibrosarcoma protuberans with 46,XY,t(X;7) abnormality in a child. Cancer Genet Cytogenet. 1995; 80: 75–7
Mandahl N, Heim S, Willen H, et al. Supernumerary ring chromosome as the sole cytogenetic abnormality in a dermatofibrosarcoma protuberans. Cancer Genet Cytogenet. 1990; 49: 273–5
Green JJ, Heymann RH. Dermatofibrosarcoma protuberans occurring in smallpox vaccination scar. J Am Acad Dermatol. 2003; 48: S54–5
Keshen TH, Cedema PS, Savell Jr VH, et al. Clinical and pathological features of pediatric dermatofibrosarcoma protuberans. Ann Plast Surg. 1995; 35: 633–7
McKee PH, Fletcher CDM. Dermatofibrosarcoma protuberans presenting in infancy and childhood. J Cutan Pathol. 1991; 18: 241–6
McPeak CJ, Cruz T, Nicastri AD. Dermatofibrosarcoma protuberans: an analysis of 86 cases: five with metastasis. Ann Surg. 1967; 166: 803–16
Burkhardt BR, Soule EH, Winkelmann RK, et al. Dermatofibrosarcoma protuberans: study of fifty-six cases. Am J Surg. 1966; 111: 638–44
Bouyssou-Gauthier ML, Labrousse F, Longis B, et al. Dermatofibrosarcoma protuberans in childhood. Pediatr Dermatol. 1997; 14: 463–5
Garg SK, Subbuswamy SG, Alabi JO, et al. Dermatofibrosarcoma protuberans in Northern Nigeria: a clinico-pathological review of 17 cases. Clin Oncol. 1978; 4: 113–22
Altman DA, Nickoloff BJ, Fivenson DP. Differential expression of factor XIIIa and CD34 in cutaneous mesenchymal tumors. J Cutan Pathol. 1993; 16: 154–8
McGregor JK. Role of surgery in the management of dermatofibrosarcoma protuberans. Ann Surg. 1961; 154: 255–8
Teirrer-Lacombe MJ, Gilloub L, Maire G, et al. Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data. Am J Surg Pathol. 2003; 27 (1): 27–39
Checketts SR, Hamilton TK, Baughman RD. Congenital and childhood dermatofibrosarcoma protuberans: a case report and review of the literature. J Am Acad Dermatol. 2000; 42: 907–13
Schmoeckel C, Albini A, Krieg T, et al. The fibroblastic nature of dermatofibrosarcoma protuberans: morphological investigations in vivo and in vitro. Arch Dermatol Res. 1985; 278: 138–47
Dupree WB, Langloss JM, Weiss SW. Pigmented dermatofibrosarcoma protuberans (Bednar tumor): a pathologic, ultrastructural and immunohistochemical study. Am J Surg Pathol. 1985; 9: 630–9
Abenoza P, Lillemoe T. CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. Am J Dermatopathol. 1993; 15: 429–34
Weiss SW, Nickoloff BJ. CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am J Surg Pathol. 1993; 17: 1039–45
Kutzner H. Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin fixed, paraffin-embedded tissue. J Am Acad Dermatol. 1993; 28: 613–7
Shmookler BM, Enzinger FM. Giant cell fibroblastoma: a peculiar childhood tumor [abstract]. Lab Invest. 1982; 46: 76A
Khan H, Fekete E, From L. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa. Hum Pathol. 2001; 32: 50–6
Kransdorf MJ, Meis Kindblom JM. Dermatofibrosarcoma protuberans: radiologic appearance. AJR Am J Roentgenol. 1994; 163: 391–4
Sato N, Kimura K, Tomita Y. Recurrent dermatofibrosarcoma protuberans with myxoid and fibrosarcomatous changes paralleled by loss of CD34 expression. J Dermatol. 1995; 22: 665–72
Bashara ME, Jules KT, Potter GK. Dermatofibrosarcoma protuberans: 4 years after local trauma. J Foot Surg. 1992; 31: 160–5
Hoffmann E. Uber das Krollentreibende Fibrosarkom der Haut (Dermatofibrosarkoma protuberans). Dermal Ztschr. 1925; 43: 1–28
Kahn TA, Liranzo MO, Vidimos AT, et al. Pathological case of the month: congenital dermatofibrosarcoma protuberans. Arch Pediatr Adolesc Med. 1996; 150: 549–50
Mbonde MP, Amir H, Kitinya JN. Dermatofibrosarcoma protuberans: a clinicopathological study in an African population. East Aft Med J. 1996; 73: 410–3
Rowsell AR, Poole MD, Godfrey AM. Dermatofibrosarcoma protuberans: the problems of surgical management. Br J Plast Surg. 1986; 39: 262–4
Smola MG, Soyer HP, Scharnagl E. Surgical treatment of dermatofibrosarcoma protuberans: a retrospective study of 20 cases with review of literature. Fur J Surg Oncol. 1991; 17: 447–53
Acknowledgment
No sources of funding were used to assist in the preparation of this case report. The authors have no conflicts of interest that are directly relevant to the content of this case report.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bukhari, I., Al Akloby, O. & Bedaiwi, Y. Dermatofibrosarcoma Protuberans at the Site of a Central Venous Line. Am J Clin Dermatol 6, 61–64 (2005). https://doi.org/10.2165/00128071-200506010-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128071-200506010-00007